Editorial: Polycystic ovarian syndrome in adolescence

• by Rajni Sharma

• May 11, 2026

Association between bisphenol exposure and polycystic ovary syndrome risk: an integrated systematic review and meta-analysis

• by Zongying Gui, Huizhen Lin, Chuhan Wang, Yingsha Yao

• June 11, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

• by Kathryn Wighton

• May 21, 2026

• 2 min

Integrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications

• by Prasanth Babu Nandagopal, Gopika Jayakrishnan, Anu Varghese Kaithamattathil, Venkatraman Manickam

• May 28, 2026